Century Therapeutics, Inc. (IPSC) vs Sol-Gel Technologies Ltd. (SLGL)
A side-by-side comparison of Century Therapeutics, Inc. and Sol-Gel Technologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IPSC
Century Therapeutics, Inc.
$1.36HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
SLGL
Sol-Gel Technologies Ltd.
$75.75HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — IPSC vs SLGL
growth of $100 · dividends reinvested · last 5yIPSC -93.5% (-42.1%/yr)SLGL -34.2% (-8.0%/yr)SLGL compounded faster over this window
Log scale — wide-divergence pair
IPSC SLGL
IPSC vs SLGL: by the numbers
- •SLGL is the larger company ($248M vs $246M market cap).
- •Both run net losses; IPSC's is the smaller (-8.78% vs -910.14% net margin).
Metrics side by side
Valuation
| Metric | IPSC | SLGL |
|---|---|---|
| P/S ratio | N/A | 137.95 |
| P/B ratio | 1.06 | 5.15 |
Profitability
| Metric | IPSC | SLGL |
|---|---|---|
| Gross margin | 88.00% | 100.00% |
| Operating margin | -13.78% | -38.88% |
| Net margin | -8.78% | -910.14% |
| ROE | -47.25% | -33.97% |
| ROIC | -43.69% | -35.90% |
Growth (annualized)
| Metric | IPSC | SLGL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 17.19% |
| Total return CAGR (5Y) | -42.05% | -4.19% |
Frequently asked
- How have IPSC and SLGL total returns compared?
- Over the past 5 years, IPSC delivered -42.05% and SLGL delivered -4.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Century Therapeutics ROESol-Gel Technologies ROECentury Therapeutics operating marginSol-Gel Technologies operating marginCentury Therapeutics revenue growthSol-Gel Technologies revenue growthCentury Therapeutics free cash flowSol-Gel Technologies free cash flow
Century Therapeutics & Sol-Gel Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.